v3.25.2
Condensed Consolidated Statements of Changes in Shareholders’ Equity (Deficit) - USD ($)
$ in Thousands
Ordinary shares
Additional paid-in capital
Accumulated deficit
Total
Beginning balance at Dec. 31, 2023 $ 179 $ 41,752 $ (31,671) $ 10,260
Beginning balance (in Shares) at Dec. 31, 2023 13,051,343      
Issuance of Ordinary Shares upon completion of an initial public offering (including exercise of over-allotment option), net of offering expenses $ 27 12,259 12,286
Issuance of Ordinary Shares upon completion of an initial public offering (including exercise of over-allotment option), net of offering expenses (in Shares) 1,971,300      
Issuance of Ordinary Shares upon cashless exercise of Warrants $ 1 (1)
Issuance of Ordinary Shares upon cashless exercise of Warrants (in Shares) 95,120      
Amount classified to equity upon determination of the exercise price 599 599
Share-based compensation 185 185
Exercise of options into ordinary shares $ 5 777 782
Exercise of options into ordinary shares (in Shares) 393,651      
Net loss (1,965) (1,965)
Ending balance at Jun. 30, 2024 $ 212 55,571 (33,636) 22,147
Ending balance (in Shares) at Jun. 30, 2024 15,511,414      
Beginning balance at Dec. 31, 2024 $ 213 55,889 (35,024) $ 21,078
Beginning balance (in Shares) at Dec. 31, 2024 15,518,794     15,518,794
Share-based compensation 327 $ 327
Exercise of options into ordinary shares [1] 20 20
Exercise of options into ordinary shares (in Shares) 11,060      
Net loss (3,185) (3,185)
Ending balance at Jun. 30, 2025 $ 213 $ 56,236 $ (38,209) $ 18,240
Ending balance (in Shares) at Jun. 30, 2025 15,529,854     15,529,854
[1] Representing an amount lower than $1.